SCHEMBL2477975

SCHEMBL2477975

C[SiH](C)OC(C(C)(C)C)C1(c2cc(NC(=O)Oc3ccccc3)no2)CC1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FAAH O00519 9/20 0.38
RAF1 P04049 3/20 0.37
MAPK13 O15264 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
MAPK14 Q16539 1/20 0.37
TRPV1 Q8NER1 6/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 2/20 0.34
TSHR P16473 1/20 0.34
IDO1 P14902 1/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1010348 0.77 FAAH (0.45) FAAHTRPV1ALDH1A1MAPTIDO1
SCHEMBL30813460 0.75 FAAH (0.46) FAAHTRPV1ALDH1A1MAPTIDO1
SCHEMBL11966205 0.73 FAAH (0.42) FAAHMAPK13MAPK12MAPK11MAPK14
SCHEMBL1012949 0.73 BRAF (0.47) FAAHTRPV1ALDH1A1MAPTCYP1A2
SCHEMBL2796611 0.72 FAAH (0.39) FAAHRAF1MAPK13MAPK12MAPK11
SCHEMBL2477977 0.72 FAAH (0.39) FAAHRAF1MAPK13MAPK12MAPK11
SCHEMBL23966921 0.72 FAAH (0.47) FAAHTRPV1ALDH1A1MAPT
SCHEMBL769541 0.70 RAF1 (0.64) RAF1MAPK13MAPK12MAPK11MAPK14
SCHEMBL1012012 0.69 SMN1; SMN2 (0.54) ALDH1A1MAPTGAAIDO1MEN1
SCHEMBL897183 0.68 RAB9A (0.61) ALDH1A1GAATSHRMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376478-A2 PYRIDYLOXYINDOLES INHIBITORS OF VEGF-R2 AND USE THEREOF FOR TREATMENT OF DISEASE Novartis AG (CH) 2011-10-19 EP disclosed
WO-2010066684-A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease NOVARTIS AG (CH) 2010-06-17 WO disclosed